Looping In Profits: How Lupin Yielded Returns Of 19,661%

If you had invested ₹1 lakh in November 1999, you could have had a whopping profit of ₹2.31 crores today! This multibagger has given its investors 19,661% returns in 23 years. Let’s take a quick look at the company.

💊 Stock Name: Lupin Ltd.
💊 NSE: $LUPIN

⭐ About The Company
Lupin was established in 1968 by Desh Bandhu Gupta, a former professor at BITS-Pilani. Headquartered in Mumbai, the company is a pharmaceutical company that supplies generic medicines. The company manufactures and sells a range of anti-diabetes and anti-TB drugs to several global bodies and governments. Its expertise is in the paediatrics and asthma care segments. The company started as a firm that supplied iron and folic acid, helping the Indian government’s initiative to improve mother and child health. It was among the first to provide drugs for tuberculosis.

🌍 Pharma Giant
The company earned ₹15,000 crores in revenue and is a market leader. It has 11 manufacturing units across India. The company has two research centres, one each in Pune and Aurangabad. Internationally, Lupin is in 11 countries, including the USA, Australia, Brazil, South Africa and others. Lupin is responsible for employing more than 18,000 employees. With exports to more than 100 countries, Lupin is well-known for its over-the-counter medicines.

The founder established the Lupin Human Welfare and Research Foundation to contribute to rural development.

📺 Endorsements
The company gained popularity as a result of endorsement from amateur boxer and politician, Mary Kom. The company is trusted in the international markets for its state-of-the-art technology for providing medical solutions.

💰 Stock Value
💵 On November 11, 1999, the company’s shares were trading at ₹3.77, while they were priced at ₹745 as of November 11, 2022.